Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Reset all filters
01 8Capsule
02 5Granule / Pellet
03 1Orodispersible Tablet
04 1Powder
05 14Tablet
Reset all filters
01 29Germany
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Application : Coating Systems & Additives, Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Category : Coating Systems & Additives, Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100-55
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral